TESTOSTERONE ENANTHATE
- Product NDC
- 55150-336
- 11-digit product format
- 551500336
- Labeler code
- 55150
- Product ID
- 55150-336_87d5a456-b364-457b-a071-cfce20f0a780
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- TESTOSTERONE ENANTHATE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Eugia US LLC
- Application
- ANDA212659
- Marketing category
- ANDA
- Marketing start
- 2024-02-28
- Substance
- TESTOSTERONE ENANTHATE
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TESTOSTERONE ENANTHATE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TESTOSTERONE ENANTHATE | 200 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7Z6522T8N9 |
| Rxcui | 835809 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55150-336-01 | TESTOSTERONE ENANTHATE | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 4 |
| 55150-336-01 | TESTOSTERONE ENANTHATE | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 5 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55150-336 | TESTOSTERONE ENANTHATE INJECTION, SOLUTION [EUGIA US LLC] | 2 | Current NDC, 2 package rows | 20250326_82a98132-9d5f-40a5-8c4f-f52f2a5de60e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 55150-336-01 | 55150033601 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-336-01) / 5 mL in 1 VIAL, MULTI-DOSE | 2024-02-28 | No | No | Current |